Frovatriptan

CAS 158747-02-5

Overview

Frovatriptan is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation

Anant Labs manufacture and furnish high quality Frovatriptan impurities for global markets. Our Frovatriptan EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Frovatriptan

CAS 158747-02-5In Stock

Technical Data

CAS158747-02-5

Mol. FormulaC₁₄H₁₇N₃O

Mol. Weight243.31 g/mol

IUPAC(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide

SMILESCN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N

InChIInChI=1S/C14H17N3O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18)/t9-/m1/s1

InChI KeyXPSQPHWEGNHMSK-SECBINFHSA-N

Note: We are upgrading our system, Cat No will change.

Synonyms

Frovatriptan158747-02-5MiguardAllergo filmtablettenSB 209509(3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamideH82Q2D5WA7DTXSID00230801H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (R)-(3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboximidic acid